Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunobinop for postsurgical dental pain
NCT01900795Phase 2Terminated
- Sponsor
- Purdue Pharma
- Start
- Jul 2013
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunobinop in Persistent postsurgical pain (PPSP), sponsored by Purdue Pharma. Started Jul 2013; status: terminated.
02
Drugs
sunobinop
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT01900795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01900795.